STERIS plc Files DEF 14A on Executive Compensation
Ticker: STE · Form: DEF 14A · Filed: Jun 12, 2024 · CIK: 1757898
Sentiment: neutral
Topics: executive-compensation, proxy-statement, corporate-governance
TL;DR
STERIS DEF 14A out: exec comp details for FY24, incl. stock/option awards for Rosebrough Jr. & others.
AI Summary
STERIS plc filed a DEF 14A on June 12, 2024, detailing executive compensation and other corporate matters for the fiscal year ending March 31, 2024. The filing includes information on stock awards, option awards, and changes in the fair value of equity awards for key personnel such as Walter M. Rosebrough Jr. and NonPeoNeoMember. It also provides financial data for the fiscal years 2020 through 2023.
Why It Matters
This filing provides transparency into how STERIS plc compensates its top executives, which can influence investor perception and executive decision-making.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and corporate governance, not indicating immediate financial risk.
Key Numbers
- 2024 — Fiscal Year (The filing covers the fiscal year ending March 31, 2024.)
- 2020-2023 — Fiscal Years (Financial data is provided for these past fiscal years.)
Key Players & Entities
- STERIS plc (company) — Filer of the DEF 14A
- Walter M. Rosebrough Jr. (person) — Executive mentioned in compensation details
- 0001757898 (company) — Central Index Key for STERIS plc
- 20240612 (date) — Filing date
- 20240801 (date) — Report period end date
- 0331 (date) — Fiscal year end
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit proxies from shareholders in connection with annual or special meetings of security holders. It provides detailed information about matters to be voted on, including executive compensation, director nominations, and other corporate governance issues.
Who is Walter M. Rosebrough Jr. in the context of this filing?
Walter M. Rosebrough Jr. is identified as a member in relation to executive compensation details, specifically concerning option awards and stock awards for the fiscal year 2020-2021.
What is the fiscal year end for STERIS plc?
The fiscal year end for STERIS plc is March 31st (0331).
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on June 12, 2024 (20240612).
What type of business is STERIS plc primarily involved in?
STERIS plc is primarily involved in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, with SIC code 3842.
Filing Stats: 4,597 words · 18 min read · ~15 pages · Grade level 12.3 · Accepted 2024-06-12 16:16:18
Key Financial Figures
- $0.001 — of record of ordinary shares, par value $0.001 per share, of the Company ("Ordinary Sh
- $5,138.7 m — d full year revenues increased 13.3% to $5,138.7 million, compared with $4,536.3 million i
- $4,536.3 million — 3.3% to $5,138.7 million, compared with $4,536.3 million in fiscal 2023. As reported full year
- $378.2 m — orted full year net income increased to $378.2 million, or $3.83 per diluted share, comp
- $3.83 — income increased to $378.2 million, or $3.83 per diluted share, compared with $107.0
- $107.0 m — $3.83 per diluted share, compared with $107.0 million, or $1.07 per diluted share, in t
- $1.07 — share, compared with $107.0 million, or $1.07 per diluted share, in the prior year. F
- $206.4 million — net income was negatively impacted by a $206.4 million pre-tax loss recognized upon reclassifi
- $44.4 million — cludes pre-tax restructuring charges of $44.4 million related to the recently initiated restr
- $490.6 — net income was negatively impacted by a $490.6 pre-tax, non-cash impairment charge rel
- $877.6 m — come (see Appendix A) increased 6.7% to $877.6 million, or $8.83 per diluted share, comp
- $8.83 — A) increased 6.7% to $877.6 million, or $8.83 per diluted share, compared with $822.2
- $822.2 m — $8.83 per diluted share, compared with $822.2 million, or $8.20 per diluted share, in f
- $8.20 — share, compared with $822.2 million, or $8.20 per diluted share, in fiscal 2023. (1)
- $973.3 m — ions for fiscal 2024 increased 28.5% to $973.3 million, compared with $756.9 million in
Filing Documents
- d736605ddef14a.htm (DEF 14A) — 1890KB
- g7366051.jpg (GRAPHIC) — 9KB
- g7366054.jpg (GRAPHIC) — 10KB
- g736605g01g01.jpg (GRAPHIC) — 33KB
- g736605g03k95.jpg (GRAPHIC) — 13KB
- g736605g04a00.jpg (GRAPHIC) — 15KB
- g736605g15j64.jpg (GRAPHIC) — 16KB
- g736605g19a19.jpg (GRAPHIC) — 30KB
- g736605g19b19.jpg (GRAPHIC) — 50KB
- g736605g20a20.jpg (GRAPHIC) — 35KB
- g736605g20b20.jpg (GRAPHIC) — 49KB
- g736605g21b21.jpg (GRAPHIC) — 34KB
- g736605g22a22.jpg (GRAPHIC) — 29KB
- g736605g22b22.jpg (GRAPHIC) — 52KB
- g736605g23a23.jpg (GRAPHIC) — 50KB
- g736605g23b23.jpg (GRAPHIC) — 53KB
- g736605g26g01.jpg (GRAPHIC) — 37KB
- g736605g26g02.jpg (GRAPHIC) — 38KB
- g736605g26g03.jpg (GRAPHIC) — 37KB
- g736605g27s30.jpg (GRAPHIC) — 10KB
- g736605g30a27.jpg (GRAPHIC) — 14KB
- g736605g32e73.jpg (GRAPHIC) — 16KB
- g736605g43c67.jpg (GRAPHIC) — 49KB
- g736605g49a10.jpg (GRAPHIC) — 62KB
- g736605g49b10.jpg (GRAPHIC) — 43KB
- g736605g74p14.jpg (GRAPHIC) — 12KB
- g736605g74q96.jpg (GRAPHIC) — 36KB
- g736605g74q97.jpg (GRAPHIC) — 35KB
- g736605g74q98.jpg (GRAPHIC) — 51KB
- 0001193125-24-159955.txt ( ) — 5372KB
- ste-20240331.xsd (EX-101.SCH) — 5KB
- ste-20240331_def.xml (EX-101.DEF) — 5KB
- ste-20240331_lab.xml (EX-101.LAB) — 7KB
- ste-20240331_pre.xml (EX-101.PRE) — 4KB
- d736605ddef14a_htm.xml (XML) — 503KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 41 Compensation Discussion and Analysis 41 Report of the Compensation and Organization Development Committee 62 Compensation and Organization Development Committee Interlocks and Insider Participation 63 Tabular and Other Executive Compensation Disclosure 63 Potential Payments to Named Executive Officers Upon Termination of Employment or Change in Control 70 CEO Pay Ratio 79 Pay Versus Performance 81 NON-EMPLOYEE DIRECTOR COMPENSATION 85 Description of Director Compensation for Fiscal 2024 85 Director Compensation Table for Fiscal 2024 86 NON-EMPLOYEE DIRECTOR STOCK OWNERSHIP GUIDELINES 87 Notice of Annual Meeting of Shareholders and 2024 Proxy Statementi Table of Contents Table of Contents 88 Greater than 5% Owners 88 Stock Ownership of Directors and Executive Officers 89 Shares and Career Restricted Stock Units 90 SHAREHOLDER NOMINATIONS OF DIRECTORS AND NOMINEE CRITERIA 91 SHAREHOLDER PROPOSALS 94 MISCELLANEOUS MATTERS 96 ANNUAL REPORT 97 APPENDIX A A-1 ii Notice of Annual Meeting of Shareholders and 2024 Proxy Statement Table of Contents PROXY SUMMARY This summary highlights certain information contained elsewhere in this Proxy Statement or in the other documents being distributed or made available to shareholders in conjunction with this Proxy Statement, but does not contain all the information you should consider prior to casting your vote. Therefore, you should read this entire Proxy Statement carefully before voting. General Information Meeting Date: August 1, 2024 Meeting Time: 9:00 a.m. Dublin Time (4:00 a.m. Eastern Daylight Saving Time) Meeting Location: 70 Sir John Rogerson's Quay Dublin 2, Ireland Record Date: Close of business in New York June 3, 2024 Stock Symbol: STE Exchange: New York Stock Exchange Shares Outstanding on Record Date: 98,853,221 Ordinary Shares Registrar and